Product
carbon-negative, non-GMO, FDA approved and EFSA-regulated, highly functional white proteins
- Wholesaler
- Agriculture & Food
- Distribution Partner
- Health Biotechnology
- Climate & Environmental Tech
- Advanced Manufacturing & Advanced Materials
Co-founder & CEO
Solmeyea
Athens, Greece
Environ. Engineer leading Solmeyea Biotech, producing healthy functional food ingredients from CO₂ and partnering with top B2C food CPGs/manufacturers
Co-founder & CEO of Solmeyea, a European industrial biotech company developing a new generation of sustainable proteins by converting captured CO₂ into food-grade ingredients through advanced fermentation.
Solmeyea has developed and validated its proprietary two-step CO₂-to-protein platform at TRL 8 and operates a 1,200 m² demonstration facility in Athens. Our flagship MEY™ Protein is a non-GMO, highly versatile protein ingredient designed for applications across beverages, nutrition, dairy alternatives, bakery, snacks and other food categories.
We are now transitioning from demonstration to industrial scale and developing our first-of-a-kind commercial facility in Europe. Solmeyea has secured approximately €7.5M in cumulative European grant funding through programmes including the EIC Accelerator, CBE JU, EIT Food and ESA, and is currently structuring its Series A and industrial financing round.
At SWITCH, I am particularly interested in meeting strategic investors, growth and climate-tech funds, family offices, corporate investors and industrial partners interested in biotechnology, fermentation, sustainable food, carbon utilisation and the decarbonisation of global food production.
Product
carbon-negative, non-GMO, FDA approved and EFSA-regulated, highly functional white proteins
Partnership
"MEY Proteins" - B2B Food ingredients' trials
B2B Food ingredients' taste and formulation trials and tests
Partnership
industrial scale CO2 Utilisation
explore options for collaboration using Solmeyea's IP-protected CO2 utilisation biotechnology